Ann: Oral Devices and Cannabinoid Sales Update, page-25

That previous corresponding period's sales $340K.

Last quarter we had sales of 338K with combined dental biz + medicinal cannabis. But medicinal cannabis only comprised $109K.

Regardless, seems that this quarter IHL is expecting revenue to be significantly higher than $340K.
With last quarter's MM sales only being $109K, we can expect at least 3x growth from those numbers to get to the same level as last years Q2.

But significantly higher? I wouldn't be surprised to see IHL post say $500K in revenues and also add a 400% growth in sales from last quarter to the quarterly tag. Joel did say when the time is right he wants to put the INCANNEX oils and inhalers business up in lights in their own right.
That's all without considering how cost-effective their strategy is compared to the dental biz which was unprofitable. Add Sud's $480K oppies conversion that was done this quarter, and we really could be seeing the best looking quarterly report in IHL history.